Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with a compelling potential upside of 38.45%. As..
As one of the largest players in the healthcare sector, McKesson Corporation (NYSE: MCK) offers a compelling investment opportunity for those looking to tap into the medical distribution industry. With..
Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, has caught the eye of individual investors with its robust revenue growth and a promising potential upside. With..
Charles River Laboratories International, Inc. (NYSE: CRL) presents an intriguing opportunity for investors looking to tap into the healthcare sector’s growth, particularly in diagnostics and research. This Massachusetts-based company has..
Halozyme Therapeutics, Inc. (NASDAQ: HALO) is emerging as a noteworthy player in the biotechnology sector, offering intriguing opportunities for investors keen on the healthcare space. With a market capitalization of..
Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector specializing in medical devices, continues to capture investor interest with its innovative cardiovascular solutions and promising market outlook...
AstraZeneca PLC (AZN), a leading biopharmaceutical company based in the United Kingdom, remains a compelling choice for investors seeking exposure to the healthcare sector. With a market capitalization of $294.17..
Fresenius Medical Care AG (FMS), a global leader in the healthcare sector with a focus on medical care facilities, is currently trading at $22.77 on the US market. Known for..
Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, offers a compelling narrative for investors seeking opportunities in healthcare innovation. With a market capitalization of $18.84 billion, Incyte..
Summit Therapeutics Inc. (NASDAQ: SMMT) has captured the attention of healthcare investors with its intriguing potential upside of 40.93%, as reflected in the average target price of $31.12. This biopharmaceutical..
Doximity, Inc. (NYSE: DOCS) is capturing investor attention with a notable 57.32% potential upside, according to recent analyst ratings. As a leading digital platform for medical professionals, Doximity operates within..
Tempus AI, Inc. (NASDAQ: TEM), a burgeoning player in the healthcare information services industry, is making waves with its innovative technology platform that aims to revolutionize how healthcare providers interact..
Corcept Therapeutics Incorporated (NASDAQ: CORT) has been making waves in the biotechnology sector, captivating investor interest with its robust focus on developing treatments for severe endocrinologic, oncologic, metabolic, and neurologic..
Illumina, Inc. (NASDAQ: ILMN) stands as a beacon in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $19.43 billion, Illumina is a formidable..
Bio-Techne Corp (NASDAQ: TECH), a stalwart in the biotechnology sector, has captured investor attention with a compelling potential upside of 33.37%. Headquartered in Minneapolis, Minnesota, Bio-Techne develops, manufactures, and sells..
Solventum Corporation (SOLV), a prominent player in the healthcare industry, offers a diverse range of medical instruments and supplies. With a current market capitalization of $11.89 billion, SOLV has captured..
Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, stands at the intersection of medical distribution and value-added services. With a significant market capitalization of $8.9 billion,..
Chemed Corporation (NYSE: CHE), a notable player in the healthcare sector, continues to capture investor attention with its robust operational segments and strategic market positioning. With a market cap of..
As one of the titans in the healthcare sector, Novartis AG (NVS) continues to command attention from both seasoned and new investors. Headquartered in Basel, Switzerland, this pharmaceutical giant is..
Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to capture the attention of investors worldwide with its robust market cap of $547.64 billion and a significant..
